Maria Pasquale
No más puestos en curso
Fortuna: 4 M $ al 31/05/2024
Origen de la red de primer grado Maria Pasquale.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 31 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Maria Pasquale a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Biotechnology | Chairman Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Public Communications Contact | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal General Counsel | |
| CRISPR THERAPEUTICS AG | Biotechnology | Director/Board Member Director/Board Member | |
| University of Pennsylvania | College/University | Director/Board Member Graduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Masters Business Admin | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Investor Relations Contact | |
| The Johns Hopkins University | College/University | Corporate Officer/Principal Undergraduate Degree | |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Director/Board Member | |
| RUBIUS THERAPEUTICS | Biotechnology | Chief Executive Officer Director/Board Member | |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| BELLICUM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| TANGO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Investment Banks/Brokers | Analyst-Equity | |
| Washington University School of Medicine | College/University | Doctorate Degree | |
| ENDOCYTE, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CARGO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Doctorate Degree | |
| GALAPAGOS NV | Biotechnology | Director/Board Member | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Director/Board Member | |
Artbio, Inc.
 Artbio, Inc. Hospital/Nursing ManagementHealth Services Artbio, Inc. is a company that is focused on redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building an ecosystem that maximizes their potential. Artbio is based in Cambridge, MA and has subsidiaries in Norway. The company puts the patient at the core of everything they do. The company was founded in 2021 by Emanuele Ostuni, Roy Hartvig Larsen, and Øyvind Sverre Bruland. Emanuele Ostuni has been the CEO since 2021. | Hospital/Nursing Management | Director/Board Member | |
Vetter Pharma International GmbH
 Vetter Pharma International GmbH Medical DistributorsDistribution Services Part of Vetter Pharma-Fertigung Verwaltungs GmbH, Vetter Pharma International GmbH is a pharmaceutical service provider that offers comprehensive fill-and-finish services from clinical development to commercialization and beyond. The company is based in Ravensburg, Germany. The German company uses robust, well-controlled testing procedures to verify the quality of every product they release. Vetter is a family-owned company that provides expert manufacturing guidance for injectable drug products. The company has an exclusive collection of in-depth videos that customers can explore. Recently, they responded to increasing market demand by implementing additional equipment for aseptic production and expanding storage capacities at the clinical site. The company was founded in 2009, and the CEO is Peter Sölkner. | Medical Distributors | Director/Board Member | |
E. Merck KG
 E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Asher Biotherapeutics, Inc.
 Asher Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Asher Biotherapeutics, Inc. engages in the research and development of immunotherapy for cancer. The company was founded by Ivana Djuretic and Andy Yeung in 2019 and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
MOMA Therapeutics, Inc.
 MOMA Therapeutics, Inc. BiotechnologyHealth Technology MOMA Therapeutics, Inc. operates as a biotechnology firm. The company was founded by Dorothee Kern, Eva Nogales, Johannes Walter, and Timur Yusufzai and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
| Bryn Mawr College | College/University | Undergraduate Degree | |
| ALLERGAN PLC | Pharmaceuticals: Major | Investor Relations Contact | |
| ZAI LAB LIMITED | Biotechnology | Investor Relations Contact | |
| Murray State University (Kentucky) | College/University | Undergraduate Degree | |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Insitro, Inc.
 Insitro, Inc. BiotechnologyHealth Technology Insitro, Inc. engages in engages in the discovery and development of drug products. Its approach include population scale data, cell-based disease models, biology at scale, cutting-edge machine learning, and predictive insights and new medicines. The company was founded by Daphne Koller and is headquartered in Portola Valley, CA. | Biotechnology | Director/Board Member | |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Chairman | |
CIBA Vision GmbH (Germany)
 CIBA Vision GmbH (Germany) Electronic ComponentsElectronic Technology Part of Alcon AG, CIBA Vision GmbH is a company based in Grosswallstadt, Germany. CIBA Vision GmbH manufactures and markets contact lenses. The German company was founded in 1983. The CEO is Norbert Dörr. | Electronic Components | Director/Board Member | |
| KARA THER | Pharmaceuticals: Major | Director/Board Member | |
| The Pennsylvania State University | College/University | Undergraduate Degree | |
Gliknik, Inc.
 Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | Pharmaceuticals: Major | Director/Board Member | |
| DURATA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| VERASTEM, INC. | Biotechnology | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 39 |
| Alemania | 5 |
| Suiza | 3 |
| Bélgica | 2 |
| Dinamarca | 2 |
Sectorial
| Health Technology | 33 |
| Consumer Services | 10 |
| Finance | 5 |
| Commercial Services | 3 |
| Health Services | 2 |
Operativa
| Director/Board Member | 122 |
| Corporate Officer/Principal | 71 |
| Independent Dir/Board Member | 58 |
| Undergraduate Degree | 25 |
| Chief Tech/Sci/R&D Officer | 19 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Paul Brooke | 32 |
| Wendy Dixon | 25 |
| Pablo Cagnoni | 24 |
| Paul Friedman | 21 |
| David Gryska | 20 |
| Reid Huber | 16 |
| Otis Brawley | 15 |
| Susanne Antonie Schaffert | 13 |
| Katherine High | 12 |
| Edmund Harrigan | 10 |
| Michael Howell | 10 |
| Bryant Lim | 9 |
| Victor Sandor | 9 |
| Christine K. Chiou | 9 |
| Christiana Stamoulis | 8 |
- Bolsa de valores
- Insiders
- Maria Pasquale
- Conexiones Empresas
